| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/08/2004 | CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| 09/07/2004 | US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives |
| 09/07/2004 | US6787651 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents |
| 09/07/2004 | US6787561 Benzimidazole compounds |
| 09/07/2004 | US6787558 Neuropeptide y receptor antagonists, for treating arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity |
| 09/07/2004 | US6787556 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 09/07/2004 | US6787555 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure |
| 09/07/2004 | US6787550 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/07/2004 | US6787546 Heterocycle derivatives and drugs |
| 09/07/2004 | US6787543 Preparation of tachykinin antagonists; substituted nitrogen-containing heterocycles |
| 09/07/2004 | US6787542 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
| 09/07/2004 | US6787538 Hormone replacement therapy; agonists, antagonists; antiestrogens with little to no intrinsic estrogenicity |
| 09/07/2004 | CA2140146C Process for preparing indole derivatives containing a 1,2,4-triazol-1-yl substituent |
| 09/02/2004 | WO2004074279A1 Methods of making 6-[(4,5-dihydro-1h-imidazol-2-yl)amino-]-7-methyl-1h-benzimidazole-4-carbonitrile and its preferred salt form |
| 09/02/2004 | WO2004074274A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | WO2004074258A1 Novel sulphated imidazole derivatives, method for production thereof, novel intermediates obtained, application thereof as medicaments and pharmaceutical compositions comprising the above |
| 09/02/2004 | WO2004074257A1 Non-nucleoside reverse transcriptase inhibitors |
| 09/02/2004 | WO2004074250A1 Novel compounds and compositions containing the same |
| 09/02/2004 | WO2004074244A2 Pyrimidine compounds |
| 09/02/2004 | WO2004074243A2 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 09/02/2004 | WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | WO2004058730A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 09/02/2004 | WO2004050637A3 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 09/02/2004 | WO2004049797A3 Pesticidal sulphonylaminopyrazoles |
| 09/02/2004 | WO2004039352A3 Amorphous form of losartan potassium |
| 09/02/2004 | WO2004035569A3 Novel compounds with antibacterial activity |
| 09/02/2004 | WO2004014851A3 Tyrosine kinase inhibitors |
| 09/02/2004 | WO2003101954A3 Nf-kb inhibitors and uses thereof |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/02/2004 | US20040171843 Process for preparing losartan potassium with improved flow ability |
| 09/02/2004 | US20040171799 Method of the solid phase synhesis of pyrrole-imidazole polyamide |
| 09/02/2004 | US20040171649 Intermediates for anthranilic amide insecticides and blood coagulation factor Xa inhibitors |
| 09/02/2004 | US20040171634 Anticancer, antitumor agents, antiarthritic agents |
| 09/02/2004 | US20040171630 both receptor-type and non-receptor type tyrosine kinases; to treat angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, |
| 09/02/2004 | US20040171617 treatment for disorders and diseases, such as chronic inflammation, tissue breakdown and cancer |
| 09/02/2004 | US20040171614 Novel gamma secretase inhibitors |
| 09/02/2004 | US20040171606 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/02/2004 | US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
| 09/02/2004 | US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
| 09/02/2004 | US20040171099 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations |
| 09/02/2004 | US20040171075 Modulation of protein functionalities |
| 09/02/2004 | DE10307142A1 Substituierte N-Aryl-Stickstoffheterocyclen Substituted N-aryl nitrogen heterocycles |
| 09/02/2004 | CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/02/2004 | CA2517002A1 Methods of making 6-[(4,5-dihydro-1h-imidazol-2-yl)amino-]-7-methyl-1h-benzimidazole-4-carbonitrile and its preferred salt form |
| 09/02/2004 | CA2516590A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | CA2515570A1 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 09/01/2004 | EP1452527A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 09/01/2004 | EP1452526A1 Indole compound and medicinal use thereof |
| 09/01/2004 | EP1452525A1 Amide derivatives and drugs |
| 09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 09/01/2004 | EP1451185A1 Indole-2-carboxamides as factor xa inhibitors |
| 09/01/2004 | EP1451177A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 09/01/2004 | EP1451160A2 Pyrazole-amides and-sulfonamides |
| 09/01/2004 | EP1451154A2 Inhibitors of cytosolic phospholipase a2 |
| 09/01/2004 | EP1451153A1 Nk1 antagonists |
| 09/01/2004 | EP1450901A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| 09/01/2004 | EP1450808A1 Quinazoline derivatives for the treatment of t cell mediated diseases |
| 09/01/2004 | EP1450800A2 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS |
| 09/01/2004 | EP1450794A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents |
| 09/01/2004 | EP1450791A1 Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/01/2004 | EP1292594B1 Quinazoline derivatives for the treatment of tumours |
| 09/01/2004 | EP1060165B1 Method for preparing an n-substituted heterocyclic derivative using a phase-transfer catalyst |
| 09/01/2004 | EP0944621B1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 09/01/2004 | CN1525968A Compositions for prevention or treatment of hepatopathy |
| 09/01/2004 | CN1525960A Lorenz Gisela |
| 09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 08/31/2004 | US6784293 Solution and solid-phase synthesis of boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/ dihydrothiouracils |
| 08/31/2004 | US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784182 Serine protease inhibitors |
| 08/31/2004 | US6784181 Ligands for the delta receptor |
| 08/31/2004 | US6784167 17-beta-hydroxysteroid dehydrogenase-II inhibitors |
| 08/26/2004 | WO2004072068A1 Vanilloid receptor ligands and their use in treatments |
| 08/26/2004 | WO2004072064A1 Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol[4,4]-non-ene-4-one |
| 08/26/2004 | WO2004072063A1 Heteroaryl substituted pyrolls useful as inhibitors of protein kinases |
| 08/26/2004 | WO2004072062A2 Indolylmaleimide derivatives |
| 08/26/2004 | WO2004072047A1 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 08/26/2004 | WO2004072025A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071454A2 Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv |
| 08/26/2004 | WO2004071448A2 Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
| 08/26/2004 | WO2004071447A2 Substituted azole derivatives as therapeutic agents |
| 08/26/2004 | WO2004071390A2 Piperazine-2-carboxamide derivatives |
| 08/26/2004 | WO2004043354A3 Ophthalmic compositions for treating ocular hypertension |
| 08/26/2004 | WO2004018461A3 Antibacterial benzoic acid derivatives |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167333 For therapy of eosinophil-dependent inflammatory diseases |
| 08/26/2004 | US20040167224 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167198 Vasculostatic agents and methods of use thereof |
| 08/26/2004 | US20040167194 Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form |
| 08/26/2004 | US20040167193 Fungicides |
| 08/26/2004 | US20040167158 Heterocyclic compounds for the treatment of migraine |
| 08/26/2004 | US20040167142 Pyrimidinone compounds |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167122 Central nervous system disorders; anxiolytic agents; neurodegenerative disorders; obsessive compulsive disorders; schizophrenia; antidepressants; alzheimer's disease; neuropathic pain; stroke |
| 08/26/2004 | US20040167121 Indazolinone compositions useful as kinase inhibitors |